Aims and Scope of Annals of the Rheumatic Diseases
The Annals of the Rheumatic Diseases is a peer-reviewed medical journal. It is co-owned by the BMJ Group and the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes basic, clinical, and translational research and abstracts from conferences. The journal was established in 1939. It is available online by subscription and archived editions of the journal (older than one year) are available free of charge. Each issue, the editor-in-chief selects a paper to be published open access as an "Editors Choice". The editor-in-chief is Josef Smolen. Less
Key Metrics
CiteScore 

28.5
Eigenfactor 

0.05 - 0.1
H-Index 

272
Impact Factor 

>= 25
Scite Index 

0.88 5-Year SI

SJR 

Q1Immunology

SNIP 

5.22
Recommended pre-submission checks
Powered by 

Topics Covered on Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases Journal Specifications
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1935 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of the Rheumatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Annals of the Rheumatic Diseases
A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis.
- 23 Apr 2027
- Annals of the rheumatic diseases
Efficacy and safety of mufemilast in patients with Behçet's syndrome: a phase 2 randomised clinical trial.
- 1 Jul 2026
- Annals of the rheumatic diseases
Comorbidities in parents of individuals with congenital heart block: a Swedish nationwide study.
- 1 Jul 2026
- Annals of the rheumatic diseases
Response to correspondence on 'The incidence of interstitial lung disease in patients with systemic sclerosis' by Petelytska et al.
- 1 Jul 2026
- Annals of the rheumatic diseases
Response to correspondence on 'Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis' by Kaundal et al.
- 1 Jul 2026
- Annals of the rheumatic diseases
Commentary on 'Assessing the performance of AI chatbots in answering patients common questions about low back pain'.
- 1 Jul 2026
- Annals of the rheumatic diseases
A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis.
- 23 Apr 2027
- Annals of the rheumatic diseases
Efficacy and safety of mufemilast in patients with Behçet's syndrome: a phase 2 randomised clinical trial.
- 1 Jul 2026
- Annals of the rheumatic diseases
Comorbidities in parents of individuals with congenital heart block: a Swedish nationwide study.
- 1 Jul 2026
- Annals of the rheumatic diseases
Response to correspondence on 'The incidence of interstitial lung disease in patients with systemic sclerosis' by Petelytska et al.
- 1 Jul 2026
- Annals of the rheumatic diseases
Response to correspondence on 'Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis' by Kaundal et al.
- 1 Jul 2026
- Annals of the rheumatic diseases
Commentary on 'Assessing the performance of AI chatbots in answering patients common questions about low back pain'.
- 1 Jul 2026
- Annals of the rheumatic diseases